Statistics for Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1
Total visits
| views | |
|---|---|
| Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1 | 7 |
Total visits per month
| views | |
|---|---|
| octubre 2024 | 0 |
| noviembre 2024 | 0 |
| diciembre 2024 | 0 |
| enero 2025 | 0 |
| febrero 2025 | 0 |
| marzo 2025 | 0 |
| abril 2025 | 0 |
File Visits
| views | |
|---|---|
| 30_2022_Gartland_Week 96 Genotypic and Phenotypic Results of the Fostemsavir.pdf | 4 |